Skip to main content
SpringerLink
Log in

Approaches to Delineate Disulfide Connectivities in Pharmaceutical Peptides

  • Living reference work entry
  • First Online:
Modern Magnetic Resonance

  • 163 Accesses

Abstract

Disulfide-rich peptides have been developed as treatments for diseases and disorders such as diabetes and pain, and many more are being explored for their potential in drug design. Based on this potential and the enormous diversity of these peptides in nature, particularly in venoms and plants, there is significant interest in characterizing novel disulfide-rich peptides. Elucidating the disulfide-bond connectivities is a crucial step to enable the structure-function relationships to be determined, which can assist in the development of more potent and selective analogues. NMR spectroscopy can be a very convenient and powerful tool for determining the disulfide connectivities, and being a nondestructive technique allows other analyses to be subsequently carried out. The range of NMR-based approaches that have been used include simple, comparative analyses for analogues of well-characterized peptides, determination of high-resolution structures, and measurement of scalar couplings across diselenide bonds. The use of computational Bayesian methodologies is also a promising approach for determining connectivities using cysteine-only NMR data.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  1. Santos GB, Ganesan A, Emery FS. Oral administration of peptide-based drugs: beyond Lipinski’s rule. ChemMedChem. 2016;11:2245–51.

    Article  Google Scholar 

  2. Williams JA, Day M, Heavner JE. Ziconotide: an update and review. Expert Opin Pharmacother. 2008;9:1575–83.

    Article  Google Scholar 

  3. Yu SW, Rao SS. Advances in the management of constipation-predominant irritable bowel syndrome: the role of linaclotide. Therap Adv Gastroenterol. 2014;7:193–205.

    Article  Google Scholar 

  4. Chan LY, Craik DJ, Daly NL. Dual-targeting anti-angiogenic cyclic peptides as potential drug leads for cancer therapy. Sci Rep. 2016;6:35347.

    Article  Google Scholar 

  5. Carstens BB, Berecki G, Daniel JT, Lee HS, Jackson KA, Tae HS, et al. Structure-activity studies of cysteine-rich alpha-conotoxins that inhibit high-voltage-activated calcium channels via gaba(b) receptor activation reveal a minimal functional motif. Angew Chem Int Ed Engl. 2016;55:4692–6.

    Article  Google Scholar 

  6. King GF, Hardy MC. Spider-venom peptides: structure, pharmacology, and potential for control of insect pests. Annu Rev Entomol. 2013;58:475–96.

    Article  Google Scholar 

  7. Gunasekera S, Foley FM, Clark RJ, Sando L, Fabri LJ, Craik DJ, et al. Engineering stabilized vascular endothelial growth factor-A antagonists: synthesis, structural characterization, and bioactivity of grafted analogues of cyclotides. J Med Chem. 2008;51:7697–704.

    Article  Google Scholar 

  8. Wong CT, Rowlands DK, Wong CH, Lo TW, Nguyen GK, Li HY, et al. Orally active peptidic bradykinin B1 receptor antagonists engineered from a cyclotide scaffold for inflammatory pain treatment. Angew Chem Int Ed. 2012;51:5620–4.

    Article  Google Scholar 

  9. Aboye T, Meeks CJ, Majumder S, Shekhtman A, Rodgers K, Camarero JA. Design of a MCoTI-based cyclotide with angiotensin (1-7)-like activity. Molecules. 2016;21:152.

    Article  Google Scholar 

  10. Wang CK, Gruber CW, Cemazar M, Siatskas C, Tagore P, Payne N, et al. Molecular grafting onto a stable framework yields novel cyclic peptides for the treatment of multiple sclerosis. ACS Chem Biol. 2014;9:156–63.

    Article  Google Scholar 

  11. Mir R, Karim S, Kamal MA, Wilson CM, Mirza Z. Conotoxins: structure, therapeutic potential and pharmacological applications. Curr Pharm Des. 2016;22:582–9.

    Article  Google Scholar 

  12. Jin AH, Dutertre S, Kaas Q, Lavergne V, Kubala P, Lewis RJ, et al. Transcriptomic messiness in the venom duct of Conus miles contributes to conotoxin diversity. Mol Cell Proteomics. 2013;12:3824–33.

    Article  Google Scholar 

  13. Lebbe EK, Peigneur S, Wijesekara I, Tytgat J. Conotoxins targeting nicotinic acetylcholine receptors: an overview. Mar Drugs. 2014;12:2970–3004.

    Article  Google Scholar 

  14. Vetter I, Lewis RJ. Therapeutic potential of cone snail venom peptides (conopeptides). Curr Top Med Chem. 2012;12:1546–52.

    Article  Google Scholar 

  15. Hu SH, Gehrmann J, Alewood PF, Craik DJ, Martin JL. Crystal structure at 1.1 A resolution of alpha-conotoxin PnIB: comparison with alpha-conotoxins PnIA and GI. Biochemistry. 1997;36:11323–30.

    Article  Google Scholar 

  16. Wang CK, Hu SH, Martin JL, Sjogren T, Hajdu J, Bohlin L, et al. Combined X-ray and NMR analysis of the stability of the cyclotide cystine knot fold that underpins its insecticidal activity and potential use as drug scaffold. J Biol Chem. 2009;284:10672–83.

    Article  Google Scholar 

  17. Mobli M, King GF. NMR methods for determining disulfide-bond connectivities. Toxicon. 2010;56:849–54.

    Article  Google Scholar 

  18. Craik DJ. Plant cyclotides: circular, knotted peptide toxins. Toxicon. 2001;39:1809–13.

    Article  Google Scholar 

  19. Craik DJ. Seamless proteins tie up their loose ends. Science. 2006;311:1563–4.

    Article  Google Scholar 

  20. Craik DJ, Clark RJ, Daly NL. Potential therapeutic applications of the cyclotides and related cystine knot mini-proteins. Expert Opin Investig Drugs. 2007;16:595–604.

    Article  Google Scholar 

  21. Craik DJ, Cĕmažar M, Daly NL. The cyclotides and related macrocyclic peptides as scaffolds in drug design. Curr Opin Drug Discov Devel. 2006;9:251–60.

    Google Scholar 

  22. Thell K, Hellinger R, Sahin E, Michenthaler P, Gold-Binder M, Haider T, et al. Oral activity of a nature-derived cyclic peptide for the treatment of multiple sclerosis. Proc Natl Acad Sci USA. 2016;113:3960–5.

    Article  Google Scholar 

  23. Rosengren KJ, Daly NL, Plan MR, Waine C, Craik DJ. Twists, knots, and rings in proteins: structural definition of the cyclotide framework. J Biol Chem. 2003;278:8606–16.

    Article  Google Scholar 

  24. Saether O, Craik DJ, Campbell ID, Sletten K, Juul J, Norman DG. Elucidation of the primary and three-dimensional structure of the uterotonic polypeptide kalata B1. Biochemistry. 1995;34:4147–58.

    Article  Google Scholar 

  25. Gran L. Oxytocic principles of Oldenlandia affinis. Lloydia. 1973;36:174–8.

    Google Scholar 

  26. Gran L. On the effect of a polypeptide isolated from “Kalata-Kalata” (Oldenlandia affinis DC) on the oestrogen dominated uterus. Acta Pharmacol Toxicol. 1973;33:400–8.

    Article  Google Scholar 

  27. Simonsen SM, Sando L, Rosengren KJ, Wang CK, Colgrave ML, Daly NL, et al. Alanine scanning mutagenesis of the prototypic cyclotide reveals a cluster of residues essential for bioactivity. J Biol Chem. 2008;283:9805–13.

    Article  Google Scholar 

  28. Gunasekera S, Daly NL, Clark RJ, Craik DJ. Dissecting the oxidative folding of circular cystine knot miniproteins. Antioxid Redox Signal. 2009;11:971–80.

    Article  Google Scholar 

  29. Craik DJ, Daly NL, Bond T, Waine C. Plant cyclotides: a unique family of cyclic and knotted proteins that defines the cyclic cystine knot structural motif. J Mol Biol. 1999;294:1327–36.

    Article  Google Scholar 

  30. Leta Aboye T, Clark RJ, Craik DJ, Goransson U. Ultra-stable peptide scaffolds for protein engineering-synthesis and folding of the circular cystine knotted cyclotide cycloviolacin O2. ChemBioChem. 2008;9:103–13.

    Article  Google Scholar 

  31. Adams DJ, Alewood PF, Craik DJ, Drinkwater RD, Lewis RJ. Conotoxins and their potential pharmaceutical applications. Drug Dev Res. 1999;46:219–34.

    Article  Google Scholar 

  32. Lovelace ES, Armishaw CJ, Colgrave ML, Wahlstrom ME, Alewood PF, Daly NL, et al. Cyclic MrIA: a stable and potent cyclic conotoxin with a novel topological fold that targets the norepinephrine transporter. J Med Chem. 2006;49:6561–8.

    Article  Google Scholar 

  33. Clark RJ, Jensen J, Nevin ST, Callaghan BP, Adams DJ, Craik DJ. The engineering of an orally active conotoxin for the treatment of neuropathic pain. Angew Chem Int Ed. 2010;49:6545–8.

    Article  Google Scholar 

  34. Luo S, Kulak JM, Cartier GE, Jacobsen RB, Yoshikami D, Olivera BM, et al. Alpha-conotoxin AuIB selectively blocks alpha3 beta4 nicotinic acetylcholine receptors and nicotine-evoked norepinephrine release. J Neurosci. 1998;18:8571–9.

    Google Scholar 

  35. Lovelace ES, Gunasekera S, Alvarmo C, Clark RJ, Nevin ST, Grishin AA, et al. Stabilization of alpha-conotoxin AuIB: influences of disulfide connectivity and backbone cyclization. Antioxid Redox Signal. 2011;14:87–95.

    Article  Google Scholar 

  36. Dutton JL, Bansal PS, Hogg RC, Adams DJ, Alewood PF, Craik DJ. A new level of conotoxin diversity, a non-native disulfide bond connectivity in alpha-conotoxin AuIB reduces structural definition but increases biological activity. J Biol Chem. 2002;277:48849–57.

    Article  Google Scholar 

  37. Daly NL, Ekberg JA, Thomas L, Adams DJ, Lewis RJ, Craik DJ. Structures of muO-conotoxins from Conus marmoreus. Inhibitors of tetrodotoxin (TTX)-sensitive and TTX-resistant sodium channels in mammalian sensory neurons. J Biol Chem. 2004;279:25774–82.

    Google Scholar 

  38. Bende NS, Dziemborowicz S, Herzig V, Ramanujam V, Brown GW, Bosmans F, et al. The insecticidal spider toxin SFI1 is a knottin peptide that blocks the pore of insect voltage-gated sodium channels via a large beta-hairpin loop. FEBS J. 2015;282:904–20.

    Article  Google Scholar 

  39. Pineda SS, Undheim EA, Rupasinghe DB, Ikonomopoulou MP, King GF. Spider venomics: implications for drug discovery. Future Med Chem. 2014;6:1699–714.

    Article  Google Scholar 

  40. Pallaghy PK, Nielsen KJ, Craik DJ, Norton RS. A common structural motif incorporating a cystine knot and a triple-stranded b-sheet in toxic and inhibitory polypeptides. Protein Sci. 1994;3:1833–9.

    Article  Google Scholar 

  41. Skjeldal L, Gran L, Sletten K, Volkman BF. Refined structure and metal binding site of the kalata B1 peptide. Arch Biochem Biophys. 2002;399:142–8.

    Article  Google Scholar 

  42. Göransson U, Craik DJ. Disulfide mapping of the cyclotide kalata B1. Chemical proof of the cyclic cystine knot motif. J Biol Chem. 2003;278:48188–96.

    Article  Google Scholar 

  43. Mobli M, de Araujo AD, Lambert LK, Pierens GK, Windley MJ, Nicholson GM, et al. Direct visualization of disulfide bonds through diselenide proxies using 77Se NMR spectroscopy. Angew Chem Int Ed Engl. 2009;48:9312–4.

    Article  Google Scholar 

  44. Wang X, Connor M, Smith R, Maciejewski MW, Howden ME, Nicholson GM, et al. Discovery and characterization of a family of insecticidal neurotoxins with a rare vicinal disulfide bridge. Nat Struct Biol. 2000;7:505–13.

    Article  Google Scholar 

  45. Armishaw CJ, Daly NL, Nevin ST, Adams DJ, Craik DJ, Alewood PF. Alpha-selenoconotoxins, a new class of potent alpha7 neuronal nicotinic receptor antagonists. J Biol Chem. 2006;281:14136–43.

    Article  Google Scholar 

  46. de Araujo AD, Callaghan B, Nevin ST, Daly NL, Craik DJ, Moretta M, et al. Total synthesis of the analgesic conotoxin MrVIB through selenocysteine-assisted folding. Angew Chem Int Ed Engl. 2011;50:6527–9.

    Article  Google Scholar 

  47. Poppe L, Hui JO, Ligutti J, Murray JK, Schnier PD. PADLOC: a powerful tool to assign disulfide bond connectivities in peptides and proteins by NMR spectroscopy. Anal Chem. 2012;84:262–6.

    Article  Google Scholar 

  48. Klaus W, Broger C, Gerber P, Senn H. Determination of the disulphide bonding pattern in proteins by local and global analysis of nuclear magnetic resonance data: application to flavoridin. J Mol Biol. 1993;232:897–906.

    Article  Google Scholar 

  49. Koradi R, Billeter M, Wüthrich K. MOLMOL: a program for display and analysis of macromolecular structures. J Mol Graph. 1996;14:51–5. 29–32.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centre for Biodiscovery and Molecular Development of Therapeutics, Australian Institute of Tropical Health & Medicine, James Cook University, Cairns, Australia

    David Wilson & Norelle L. Daly

Authors
  1. David Wilson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Norelle L. Daly
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Norelle L. Daly .

Editor information

Editors and Affiliations

  1. Royal Society of Chemistry, London, United Kingdom

    Graham A. Webb

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this entry

Cite this entry

Wilson, D., Daly, N.L. (2017). Approaches to Delineate Disulfide Connectivities in Pharmaceutical Peptides. In: Webb, G. (eds) Modern Magnetic Resonance. Springer, Cham. https://doi.org/10.1007/978-3-319-28275-6_116-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-28275-6_116-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-28275-6

  • Online ISBN: 978-3-319-28275-6

  • eBook Packages: Springer Reference Chemistry and Mat. ScienceReference Module Physical and Materials ScienceReference Module Chemistry, Materials and Physics

Publish with us

Policies and ethics

Search

Navigation